Rhizoma Gastrodiae Tablets Market
Rhizoma Gastrodiae Tablets Market Analysis By Type (Gastrodia Elata F., G. Elata Bl. F.), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), & By Region - Global Insights to 2031
Analysis of Rhizoma Gastrodiae Tablets market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Key Questions Answered in Report
-
What are the growth prospects for rhizoma gastrodiae tablets market from 2021 to 2031?
According to Fact. MR’s analysis, demand for rhizoma gastrodiae tablets is anticipated to witness a considerable incline from 2021 to 2031 and expand at a CAGR exceeding 10%. Extensive uptake to treat chronic ailments such as liver disorders will greatly
-
Which country will generate the most promising expansion opportunities for rhizoma gastrodiae tablet manufacturers?
China is likely to emerge as the center-stage for enhanced sales of rhizoma gastrodiae tablets, expected to generate over 50% of total revenue from 2021 to 2031. Simultaneously, India is anticipated to experience a surge of 9% CAGR across the aforemention
-
Which type of rhizoma gastrodiae tablets are expected to generate maximum demand through 2031?
Fact.MR anticipates demand for gastrodia elata f. glauca rhizoma gastrodiae tablets to surge at a staggering 10% CAGR over the next ten years.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Report Also Addresses:
- Market Estimates and Forecasts (2016 to 2031)
- Key Drivers and Restraints Shaping Market Growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Brand Share and Market Share Analysis
- Key Product Innovations and Regulatory Climate
- COVID-19 Impact on Rhizoma Gastrodiae Tablets and How to Navigate
- Recommendation on Key Winning Strategies
Demand for Rhizoma Gastrodiae Tablets from 2016 to 2020 Vs Future Market Projections for 2021 to 2031
From 2016 to 2020, sales of rhizoma gastrodiae tablets were significantly high, expanding at under 10% CAGR. Increasing preference for traditional and alternative medicine over conventional allopathic ones amid rising health concerns has been driving majority of market growth.
The COVID-19 pandemic has promised significant future expansion prospects, as key healthcare providers seek to incorporate natural alternatives to reduce inflammation episodes. From 2021 to 2031, demand is likely expand at a CAGR exceeding 10% as key regions incorporate plant-based medicine to address such key problems as liver diseases.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
How is Demand for Plant-based Medicine Spurring Rhizoma Gastrodiae Tablet Sales?
Traditional herbal medicines are acquiring significant attention in the global healthcare industry. Data from the World Health Organization (W.H.O) concludes that traditional herbal medicine was effectively used to treat severe acute respiratory syndrome (SARS) in China, while 80% of Africans deployed various forms of herbal medicine.
Worldwide annual market for these products is currently valued at US$ 60 billion, and it is anticipated that traditional herbal medicine will make significant strides in the global market, with countries such as China, India, Nigeria and the U.S expected to make significant strides, eventually heightening prospects for rhizoma gastrodiae tablets.
Increasing Prevalence of Liver Disorders Opening Up New Frontiers for Rhizoma Gastrodiae Tablets?
Liver disease accounts for approximately 2 million deaths annually worldwide, half of them due to complications arising out of cirrhosis and the balance as a result of viral hepatitis and hepatocellular carcinoma, according to the National Center for Biotechnology Information.
Moreover, about 2 billion people consume alcohol worldwide and upwards of 75 million are diagnosed with alcohol-use disorders and are at risk of alcohol-associated liver disease. In addition, a significant chunk of the population also lives with fatty liver. Hence, rhizoma gastrodiae tablets are likely to prove useful in mitigating these diseases, inclining their demand.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
What are the Key Challenges to Market Expansion for Manufacturers of Rhizoma Gastrodiae Tablets?
A major challenge expected to hamper sales of rhizoma gastrodiae tablets is the limited presence of adequate manufacturers. Currently, bulk of all products manufacturing is restricted to China, attributed to the presence of regional level players.
However, certain players are attempting to expand their business in overseas markets in order to expand their geographical footprint, widening expansion prospects. Another challenge is that of regulatory approvals. Due to availability of limited literature, key authorities are unable to ascertain their effectiveness, delaying product launches.
Country-wise Analysis
How is Growing Popularity of Alternative Medicine Bolstering Rhizoma Gastrodiae Tablet Sales in the U.S.?
The market for rhizoma gastrodiae tablets in the U.S is likely to expand at under 5% CAGR until 2031. Increasing preference for herbal medicines over conventional ones is largely attributed as the chief growth driver for the region.
According to the American Botanical Council, sales of herbal products exceeded US$ 5.3 billion as of the beginning of the previous decade, climbing by 8% to reach around US$ 6 billion by 2013. It further rose to over US$ 9 billion in 2019. Hence, prospects for these medicines appear highly bright across the U.S
Why is Demand for Rhizoma Gastrodiae Tablets High in China?
China is expected to remain the epicenter for global rhizoma gastrodiae tablets, generating more than 50% of the revenue share across the forecast period. Extensive development of Traditional Chinese Medicine (TCM) underpins majority of the East Asian giant’s market growth prospects.
A plethora of chronic ailments have been addressed in China by virtue of traditional herbal-based medicine. As per the World Health Organization (W.H.O), TCM accounts for around 40% of all healthcare delivered. Hence, a number of regional level manufacturers have emerged across key provinces.
How are Growth Prospects for Rhizoma Gastrodiae Tablets Surging in India?
India is poised to exhibit a robust 9% CAGR with respect to rhizoma gastrodiae tablets sales in forthcoming years. The Indian Journal of Pharmacology estimates that 60% of registered physicians are involved in traditional and alternate systems of medicine in India.
Additionally, there are about 700,000 registered practitioners of traditional medicine, majority in Ayurveda, and around 650,000 registered practitioners of modern medicine in India. Also, heightening concerns over allopathic medicines on overall health is also spurring demand for natural medicines, thus providing impetus to market growth.
Category-wise Analysis
Why are Gastrodia Elata F. Glauca Rhizoma Gastrodiae Tablets Highly Preferred?
By type, demand for gastrodia elata f. glauca rhizoma gastrodiae tablets is likely to witness an impressive incline, at a staggering 10% CAGR until 2031. These tablets have proven highly effective in addressing a variety of ailments.
Gastrodia elata. f. glauca derived rhizoma gastrodiae tablets has been used to treat conditions such as headache, dizziness, convulsion, paralysis, rheumatism, epilepsy, strokes, spasms and lumbago.
Competitive Landscape
The rhizoma gastrodiae tablets landscape appears highly consolidated, with a major chunk of it being dominated by Chinese players. Some notable developments in the market include:
- In June 2017, Beijing Tong Ren Tang Europe Holding B.V entered a strategic co-operation agreement with the Republic of Kazakhstan for establishing a Chinese Medical Center to further Chinese Medicine
- In November 2019, Tsumura & Co. concluded its Letter of Intent regarding Tianjin China Medico Technology Co. Ltd. to forge a capital alliance with the intention of expanding its business in Traditional Chinese Medicine and ensure stable supply of crude drugs
*This list is indicative- full details about prominent rhizoma gastrodiae tablets manufacturers is available upon request.
Report Scope
| Attribute | Details |
|---|---|
| Forecast Period | 2021 to 2031 |
| Historical Data Available for | 2016 to 2020 |
| Market Analysis | US$ Mn for Value & ‘000 Units for Volume |
| Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East & Africa |
| Key Countries Covered | U.S., Canada, Brazil, Mexico, Argentina, Germany, U.K., France, Spain, Italy, Japan, China, South Korea, India, ASEAN, Australia & New Zealand, GCC, South Africa |
| Key Segments Covered | Type, Application, Region |
| Key Companies Profiled | Zhaotong Huacheng Pharmaceuticals; Guangdong Luofu Shan National Pharmaceutical Co. Ltd.; Beijing Tong Ren Tang; Guizhou Bailing Group; Guangxi Changzhou Natural Pharmaceutical Co. Ltd.; Lanzhou Foci Pharmaceutical; Shaanxi Tianyang Pharmaceutical; Taiji Group Sichuan Mianyang Pharmaceutical; Tsumura & Co. |
| Pricing | Available upon Request |
Key Market Segments Covered
-
Type :
- Gastrodia Elata F. Glauca Rhizoma Gastrodiae Tablets
- G. Elata Bl. F. Elta Rhizoma Gastrodiae Tablets
- Other Rhizoma Gastrodiae Tablets
-
Distribution Channel :
- Rhizoma Gastrodiae Tablets for Hospital Pharmacies
- Rhizoma Gastrodiae Tablets for Retail Pharmacies
- Rhizoma Gastrodiae Tablets for Online Pharmacies
-
Region :
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
- East Asia
- China
- Japan
- South Korea
- Rest of East Asia
- South Asia
- India
- ASEAN
- Rest of South Asia
- Middle East & Africa
- GCC
- South Africa
- Rest of MEA
- Oceania
- Australia & New Zealand
- Rest of Oceania
- North America
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Key Market Trends
- 4. Key Success Factors
- 5. Market Background
- 6. Global Market Volume (Units) Analysis 2016 to 2020 and Forecast, 2021 to 2031
- 7. Global Market - Pricing Analysis
- 8. Global Market Value Analysis 2016 to 2020 and Forecast, 2021 to 2031
- 9. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by Type
- 9.1. GastrodiaElata F. Glauca
- 9.2. G. Elata Bl. F. Elata
- 9.3. Others
- 10. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by Distribution Channel
- 10.1. Hospital Pharmacies
- 10.2. Retail Pharmacies
- 10.3. Online Pharmacies
- 11. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by Region
- 11.1. North America
- 11.2. Latin America
- 11.3. Europe
- 11.4. East Asia
- 11.5. South Asia
- 11.6. Oceania
- 11.7. Middle East and Africa (MEA)
- 12. North America Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 13. Latin America Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 14. Europe Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 15. South Asia Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 16. East Asia Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 17. Oceania Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 18. Middle East and Africa Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 19. Key and Emerging Countries Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 20. Market Structure Analysis
- 21. Competition Analysis
- 21.1. ZhaotongHuacheng Pharmaceuticals
- 21.2. Guangdong Luofu Shan National Pharmaceutical Co. Ltd.
- 21.3. Beijing Tong Ren Tang
- 21.4. Guizhou Bailing Group
- 21.5. Guangxi Changzhou Natural Pharmaceutical Co. Ltd.
- 21.6. Lanzhou Foci Pharmaceutical
- 21.7. Shaanxi Tianyang Pharmaceutical
- 21.8. Taiji Group Sichuan Mianyang Pharmaceutical
- 21.9. Tsumura & Co.
- 22. Assumptions and Acronyms Used
- 23. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (‘000 Units) Analysis and Opportunity Assessment 2016 to 2031, By Type
Table 02: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Type
Table 03: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Distribution Channel
Table 04: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Region
Table 05: North America Market Value (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 06: North America Market Value (US$ Mn) Analysis and Opportunity Assessment2016 to 2031, By Type
Table 07: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Distribution Channel
Table 08: Latin America Market Value (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 09: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment2016 to 2031, By Type
Table 10: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Distribution Channel
Table 11: Europe Market Value (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 12: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031,By Type
Table 13: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Distribution Channel
Table 14: South Asia Market Value (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 15: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Type
Table 16: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Distribution Channel
Table 17: East Asia Market Value (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 18: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Type
Table 19: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Distribution Channel
Table 20: Oceania Market Value (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 21: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment2016 to 2031, By Type
Table 22: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Distribution Channel
Table 23: Middle East and Africa Market Value (US$ Mn) Analysis 2016 to 2020 and Forecast2021 to 2031, By Country
Table 24: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Type
Table 25: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Distribution Channel
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Volume (in 000' Units) Analysis, 2016 to 2020
Figure 02: Global Market Volume Forecast (in 000' Units), 2021 to 2031
Figure 03: Rhizoma Gastrodiae TabletsPricing Analysis (US$) Per Product, By Region, 2020
Figure 04: Rhizoma Gastrodiae TabletsPricing Analysis (US$) Per Product, By Region, 2020
Figure 05: Global Market Value Analysis (US$ Mn), 2016 to 2020
Figure 06: Global Market Value Forecast (US$ Mn), 2021 to 2031
Figure 07: Global Market Absolute $ Opportunity, 2021 to 2031
Figure 08: Global Market Share Analysis (%),By Type, 2021 to 2031
Figure 09: Global Market Y-o-Y Analysis (%), By Type, 2021 to 2031
Figure 10: Global Market Attractiveness Analysis by Type, 2021 to 2031
Figure 11: Global Market Share Analysis (%), By Distribution Channel, 2021 to 2031
Figure 12: Global Market Y-o-Y Analysis (%), By Distribution Channel, 2021 to 2031
Figure 13: Global Market Attractiveness Analysis by Distribution Channel, 2021 to 2031
Figure 14: Global Market Share Analysis (%), By Region, 2021 to 2031
Figure 15: Global Market Y-o-Y Analysis (%), By Region, 2021 to 2031
Figure 16: Global Market Attractiveness Analysis by Region, 2021 to 2031
Figure 17: North America Market Value Share, By Type, 2021 (E)
Figure 18: North America Market Value Share, By Distribution Channel, 2021 (E)
Figure 19: North America Market Value Share, By Country, 2021 (E)
Figure 20: North America Market Value Analysis (US$ Mn), 2016 to 2020
Figure 21: North America Market Value Forecast (US$ Mn), 2021 to 2031
Figure 22: North America Market Attractiveness Analysis by Type, 2021 to 2031
Figure 23: North America Market Attractiveness Analysis by Distribution Channel, 2021 to 2031
Figure 24: North America Market Attractiveness Analysis by Country, 2021 to 2031
Figure 25: Latin America Market Value Share, By Type, 2021 (E)
Figure 26: Latin America Market Value Share, By Distribution Channel, 2021 (E)
Figure 27: Latin America Market Value Share, By Country, 2021 (E)
Figure 28: Latin America Market Value Analysis (US$ Mn), 2016 to 2020
Figure 29: Latin America Market Value Forecast (US$ Mn), 2021 to 2031
Figure 30: Latin America Market Attractiveness Analysis by Type, 2021 to 2031
Figure 31: Latin America Market Attractiveness Analysis by Distribution Channel, 2021 to 2031
Figure 32: Latin America Market Attractiveness Analysis by Country, 2021 to 2031
Figure 33: Europe Market Value Share, By Type, 2021 (E)
Figure 34: Europe Market Value Share, By Distribution Channel, 2021 (E)
Figure 35: Europe Market Value Share, By Country, 2021 (E)
Figure 36: Europe Market Value Analysis (US$ Mn), 2016 to 2020
Figure 37: Europe Market Value Forecast (US$ Mn), 2021 to 2031
Figure 38: Europe Market Attractiveness Analysis by Type,2021 to 2031
Figure 39: Europe Market Attractiveness Analysis by Distribution Channel, 2021 to 2031
Figure 40: Europe Market Attractiveness Analysis by Country, 2021 to 2031
Figure 41: South Asia Market Value Share, By Type, 2021 (E)
Figure 42: South Asia Market Value Share, By Distribution Channel, 2021 (E)
Figure 43: South Asia Market Value Share, By Country, 2021 (E)
Figure 44: South Asia Market Value Analysis (US$ Mn), 2016 to 2020
Figure 45: South Asia Market Value Forecast (US$ Mn), 2021 to 2031
Figure 46: South Asia Market Attractiveness Analysis by Type,2021 to 2031
Figure 47: South Asia Market Attractiveness Analysis by Distribution Channel, 2021 to 2031
Figure 48: South Asia Market Attractiveness Analysis by Country, 2021 to 2031
Figure 49: East Asia Market Value Share, By Type, 2021 (E)
Figure 50: East Asia Market Value Share, By Distribution Channel, 2021 (E)
Figure 51: East Asia Market Value Share, By Country, 2021 (E)
Figure 52: East Asia Market Value Analysis (US$ Mn), 2016 to 2020
Figure 53: East Asia Market Value Forecast (US$ Mn), 2021 to 2031
Figure 54: East Asia Market Attractiveness Analysis by Type,2021 to 2031
Figure 55: East Asia Market Attractiveness Analysis by Distribution Channel, 2021 to 2031
Figure 56: East Asia Market Attractiveness Analysis by Country, 2021 to 2031
Figure 57: Oceania Market Value Share, By Type, 2021 (E)
Figure 58: Oceania Market Value Share, By Distribution Channel, 2021 (E)
Figure 59: Oceania Market Value Share, By Country, 2021 (E)
Figure 60: Oceania Market Value Analysis (US$ Mn), 2016 to 2020
Figure 61: Oceania Market Value Forecast (US$ Mn), 2021 to 2031
Figure 62: Oceania Market Attractiveness Analysis by Type, 2021 to 2031
Figure 63: Oceania Market Attractiveness Analysis by Distribution Channel, 2021 to 2031
Figure 64: Oceania Market Attractiveness Analysis by Country, 2021 to 2031
Figure 65: Middle East and Africa RhizomaGastrodiae Tablets Market Value Share, By Type, 2021 (E)
Figure 66: Middle East and Africa RhizomaGastrodiae Tablets Market Value Share, By Distribution Channel, 2021 (E)
Figure 67: Middle East and Africa RhizomaGastrodiae Tablets Market Value Share, By Country, 2021 (E)
Figure 68: Middle East and Africa RhizomaGastrodiae Tablets Market Value Analysis (US$ Mn), 2016 to 2020
Figure 69: Middle East and Africa RhizomaGastrodiae Tablets Market Value Forecast (US$ Mn), 2021 to 2031
Figure 70: Middle East and Africa RhizomaGastrodiae Tablets Market Attractiveness Analysis by Type,2021 to 2031
Figure 71: Middle East and Africa RhizomaGastrodiae Tablets Market Attractiveness Analysis by Distribution Channel, 2021 to 2031
Figure 72: Middle East and Africa RhizomaGastrodiae Tablets Market Attractiveness Analysis by Country, 2021 to 2031
Figure 73: U. S. Market Value Analysis (US$ Mn), 2021 & 2031
Figure 74: U. S. Market Value Share, By Type, 2021 (E)
Figure 75: U. S. Market Value Share, By Distribution Channel, 2021 (E)
Figure 76: Canada Market Value Analysis (US$ Mn), 2021 & 2031
Figure 77: Canada Market Value Share, By Type, 2021 (E)
Figure 78: Canada Market Value Share, By Distribution Channel, 2021 (E)
Figure 79: Mexico Market Value Analysis (US$ Mn), 2021 & 2031
Figure 80: Mexico Market Value Share, By Type, 2021 (E)
Figure 81: Mexico Market Value Share, By Distribution Channel, 2021 (E)
Figure 82: Brazil Market Value Analysis (US$ Mn), 2021 & 2031
Figure 83: Brazil Market Value Share, By Type, 2021 (E)
Figure 84: Brazil Market Value Share, By Distribution Channel, 2021 (E)
Figure 85: U. K. Market Value Analysis (US$ Mn), 2021 & 2031
Figure 86: U. K. Market Value Share, By Type, 2021 (E)
Figure 87: U. K. Market Value Share, By Distribution Channel, 2021 (E)
Figure 88: Germany Market Value Analysis (US$ Mn), 2021 & 2031
Figure 89: Germany Market Value Share, By Type, 2021 (E)
Figure 90: Germany Market Value Share, By Distribution Channel, 2021 (E)
Figure 91: France Market Value Analysis (US$ Mn), 2021 & 2031
Figure 92: France Market Value Share, By Type, 2021 (E)
Figure 93: France Market Value Share, By Distribution Channel, 2021 (E)
Figure 94: Italy Market Value Analysis (US$ Mn), 2021 & 2031
Figure 95: Italy Market Value Share, By Type, 2021 (E)
Figure 96: Italy Market Value Share, By Distribution Channel, 2021 (E)
Figure 97: Spain Market Value Analysis (US$ Mn), 2021 & 2031
Figure 98: Spain Market Value Share, By Type, 2021 (E)
Figure 99: Spain Market Value Share, By Distribution Channel, 2021 (E)
Figure 100: Russia Market Value Analysis (US$ Mn), 2021 & 2031
Figure 101: Russia Market Value Share, By Type, 2021 (E)
Figure 102: Russia Market Value Share, By Distribution Channel, 2021 (E)
Figure 103: China Market Value Analysis (US$ Mn), 2021 & 2031
Figure 104: China Market Value Share, By Type, 2021 (E)
Figure 105: China Market Value Share, By Distribution Channel, 2021 (E)
Figure 106: Japan Market Value Analysis (US$ Mn), 2021 & 2031
Figure 107: Japan Market Value Share, By Type, 2021 (E)
Figure 108: Japan Market Value Share, By Distribution Channel, 2021 (E)
Figure 109: South Korea Market Value Analysis (US$ Mn), 2021 & 2031
Figure 110: South Korea Market Value Share, By Type, 2021 (E)
Figure 111: South Korea Market Value Share, By Distribution Channel, 2021 (E)
Figure 112: India Market Value Analysis (US$ Mn), 2021 & 2031
Figure 113: India Market Value Share, By Type, 2021 (E)
Figure 114: India Market Value Share, By Distribution Channel, 2021 (E)
Figure 115: ASEAN Market Value Analysis (US$ Mn), 2021 & 2031
Figure 116: ASEAN Market Value Share, By Type, 2021 (E)
Figure 117: ASEAN Market Value Share, By Distribution Channel, 2021 (E)
Figure 118: Australia Market Value Analysis (US$ Mn), 2021 & 2031
Figure 119: Australia Market Value Share, By Type, 2021 (E)
Figure 120: Australia Market Value Share, By Distribution Channel, 2021 (E)
Figure 121: New Zealand Market Value Analysis (US$ Mn), 2021 & 2031
Figure 122: New Zealand Market Value Share, By Type, 2021 (E)
Figure 123: New Zealand Market Value Share, By Distribution Channel, 2021 (E)
Figure 124: GCC Countries Market Value Analysis (US$ Mn), 2021 & 2031
Figure 125: GCC Countries Market Value Share, By Type, 2021 (E)
Figure 126: GCC Countries Market Value Share, By Distribution Channel, 2021 (E)
Figure 127: Turkey Market Value Analysis (US$ Mn), 2021 & 2031
Figure 128: Turkey Market Value Share, By Type, 2021 (E)
Figure 129: Turkey Market Value Share, By Distribution Channel, 2021 (E)
Figure 130: South Africa Market Value Analysis (US$ Mn), 2021 & 2031
Figure 131: South Africa Market Value Share, By Type, 2021 (E)
Figure 132: South Africa Market Value Share, By Distribution Channel, 2021 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What are the growth prospects for rhizoma gastrodiae tablets market from 2021-2031?
Demand for rhizoma gastrodiae tablets is anticipated to witness a considerable incline from 2021 to 2031 and expand at a CAGR exceeding 10%. Extensive uptake to treat chronic ailments such as liver disorders will greatly
Which country will generate the most promising expansion opportunities for rhizoma gastrodiae tablet manufacturers?
China is likely to emerge as the center-stage for enhanced sales of rhizoma gastrodiae tablets, expected to generate over 50% of total revenue from 2021 to 2031. Simultaneously, India is anticipated to experience a surge of 9% CAGR across the afor
Which type of rhizoma gastrodiae tablets are expected to generate maximum demand through 2031?
Demand for gastrodia elata f. glauca rhizoma gastrodiae tablets to surge at a staggering 10% CAGR over the next ten years.
Rhizoma Gastrodiae Tablets Market